IHC Inspiration Healthcare Group Plc

TIDMIHC

Inspiration Healthcare Group PLC

20 January 2020

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Sri Lankan Ministry of Health Order

Inspiration Healthcare Group plc (AIM:IHC), the global medical technology company, is delighted to confirm that it has received an order from the Ministry of Health of Sri Lanka for the supply of 15 HIE Workstations, used for diagnosing and treating Hypoxic-Ischaemic Encephalopathy in the newborn.

The Workstations comprise of the Unique+ CFM, our cerebral function monitor for diagnosing brain injury, and, the Tecotherm Neo, used to cool and warm babies who have suffered from a lack of oxygen at the time of birth. The products are used in neonatal intensive care setting.

The Company had been working on this order for a long time and its receipt does not alter the financial expectations of the company for the current year which remain in line with current forecasts.

Commenting today, Neil Campbell, Inspiration Healthcare's Chief Executive said:

"We are delighted to have received this sizeable order from the Sri Lankan Ministry of Health for the Workstations meaning an ever-growing presence for Inspiration Healthcare across international markets. It also demonstrates clearly the quality of our products and our International distribution partners who are opening up these new opportunities."

Enquiries:

 
 Inspiration Healthcare            Tel: 01455 840555 
  Group plc 
  Neil Campbell, Chief Executive 
  Officer 
  Mike Briant, Chief Financial 
  Officer 
 Nominated Adviser & Broker        Tel: 0207 397 8900 
  Cenkos Securities plc 
  Stephen Keys 
  Cameron MacRitchie 
 Cadogan PR                        Tel: 07771 713608 
  Alex Walters 
  alex.walters@cadoganpr.com 
 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRASFUFDAESSEDF

(END) Dow Jones Newswires

January 20, 2020 02:00 ET (07:00 GMT)

Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024